Wholesale Tocilizumab Actemra 400 Mg Injections

Listing ID #5980710

tocilizumab, sold under the brand name actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. it is a humanized monoclonal antibody against the interleukin-6 receptor. actemra/roactemra is approved in 116 countries for the treatment of rheumatoid arthritis (ra). it is also approved for the treatment of paediatric juvenile idiopathic arthritis (pjia), systemic juvenile idiopathic arthritis (sjia), giant cell arteritis (gca) and car-t cell-induced cytokine release syndrome (crs). actemra/roactemra is available in both subcutaneous (sc) and intravenous (iv) formulations.

actemra/roactemra is a first-in-class anti-il-6 receptor (ail-6r) therapy. il-6 is believed to play a key role in activating the inflammatory pathway that contributes to the signs and symptoms of ra and other inflammatory autoimmune conditions. actemra/roactemra binds to il-6 receptors